Development of Online EMDR Therapy System and Its Comparative Testing With Face-to-Face EMDR Therapy for Treatment of Anxiety and Depressive Disorders in Pakistan
NCT ID: NCT05785312
Last Updated: 2023-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2023-07-01
2025-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of EMDR in the Treatment of Depression and Comorbid Anxiety
NCT04976413
Symptom-specific TMS Targets for Depression and Anxiety
NCT04604210
Retrospective Analyses of TrakStar Database
NCT06917339
Demonstration Study of the Effect of the Transcranial Direct Current Stimulation (tDCS) on Depressed Patients
NCT05539131
Synchronized Transcranial Magnetic Stimulation for PTSD
NCT02981381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Face to Face Eye Movement Desensitization & Reprocessing Therapy
The standard Face to Face Eye Movement Desensitization \& Reprocessing Therapy will be applied by a trained clinical psychologist through in person face to face sessions.
Face to Face Eye Movement Desensitization & Reprocessing Therapy
The Face to Face Eye Movement Desensitization \& Reprocessing Therapy will be delivered in person inside clinician's room by following standard EMDR therapy protocol
Online Eye Movement Desensitization & Reprocessing Therapy
The Online Eye Movement Desensitization \& Reprocessing Therapy will be applied by a trained clinical psychologist through computer system by connecting through internet. For this purpose the online EMDR therapy application software will be installed
Online EMDR Therapy System
Online EMDR Therapy System will be delivered through online computer system that will be specifically designed for delivering EMDR therapy online
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Online EMDR Therapy System
Online EMDR Therapy System will be delivered through online computer system that will be specifically designed for delivering EMDR therapy online
Face to Face Eye Movement Desensitization & Reprocessing Therapy
The Face to Face Eye Movement Desensitization \& Reprocessing Therapy will be delivered in person inside clinician's room by following standard EMDR therapy protocol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients between the age of 18 to 50 years (since this study is neither on children nor on old patients).
3. Patients who have basic knowledge \& skills of computer, mobile and internet (although the recruited patients will be given training for using the online EMDR).
4. Patients do not suffer from severe neuropsychological and cognitive impairments.
5. Patients have not received any pharmacological therapy in the last three months.
6. Patients have not received any other psychotherapy like Cognitive Behavioral Therapy.
18 Months
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Khushal Khan Khattak Univeristy, Karak, Pakistan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Anwar Khan
Dr. Anwar Khan, Director and Principal Investigator, Office of Research, Innovation and Commercialization
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kushal Khan University
Lakki, Khyber Pakhtunkhwa, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12321
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.